Sandoz/NNP/B-ORG AG/NNP/I-ORG ,/,/O a/DT/O major/JJ/O Swiss/NNP/O chemical/NN/O and/CC/O pharmaceutical/JJ/O group/NN/O ,/,/O said/VBD/O that/DT/O its/PRP$/O group/NN/O sales/NNS/O rose/VBD/O 25/CD/O %/NN/O to/TO/O 9.482/CD/O billion/CD/O francs/NNS/O -LRB-/-LRB-/O $/$/O 5.80/CD/O billion/CD/O -RRB-/-RRB-/O in/IN/O the/DT/O first/JJ/O nine/CD/O months/NNS/O of/IN/O this/DT/O year/NN/O ,/,/O with/IN/O strong/JJ/O gains/NNS/O in/IN/O all/DT/O divisions/NNS/O ././O
A/DT/O year/NN/O earlier/JJR/O sales/NNS/O totaled/VBD/O 7.567/CD/O billion/CD/O francs/NNS/O ././O
Positive/JJ/O currency/NN/O rates/NNS/O and/CC/O strong/JJ/O sales/NNS/O growth/NN/O led/VBD/O to/TO/O a/DT/O substantial/JJ/O rise/NN/O in/IN/O consolidated/JJ/O profit/NN/O in/IN/O the/DT/O period/NN/O ,/,/O although/IN/O the/DT/O company/NN/O did/VBD/O n't/RB/O provide/VB/O figures/NNS/O ,/,/O as/IN/O is/VBZ/O customary/JJ/O with/IN/O Swiss/NNP/O companies/NNS/O ././O
Sandoz/NNP/B-ORG said/VBD/O it/PRP/O expects/VBZ/O a/DT/O ``/``/O substantial/JJ/O increase/NN/O ''/''/O in/IN/O consolidated/JJ/O profit/NN/O for/IN/O the/DT/O full/JJ/O year/NN/O ,/,/O barring/VBG/O major/JJ/O currency/NN/O rate/NN/O changes/NNS/O ././O
